Epstein-Barr Virus Particles (IMAGE)

Children's National Hospital

Epstein-Barr Virus Particles

Caption

Because viral infections can be controlled by T-cells, the body's infection-fighting white blood cells, the Children's National Hospital first-in-humans Phase 1 dose escalation trial aimed to determine the safety of T-cells with antiviral activity against a half dozen opportunistic viruses: adenovirus, BK virus, cytomegalovirus, Epstein-Barr virus, Human Herpesvirus 6 and human parainfluenza-3

An electron microscopy image showing three Epstein-Barr virus particles
Image credit: NIAID

Credit

NIAID

Usage Restrictions

Please credit NIAID

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.